893 studies found for:    Open Studies | "Prostatic Diseases"
Show Display Options
Rank Status Study
1 Recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
2 Not yet recruiting A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy
Conditions: Infection;   Prostatic Diseases;   Misadventure During Aspirating Needle Biopsy
Intervention: Drug: Povidone-Iodine
3 Unknown  MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
Intervention:
4 Recruiting Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome
Conditions: Prostate Cancer;   Prostatitis;   Benign Prostatic Hyperplasia
Intervention:
5 Recruiting Molecular Studies and Clinical Correlations in Human Prostatic Disease
Condition: Prostate Cancer
Intervention:
6 Recruiting Radiotherapy vs Observation for CRPC
Condition: Hormone Refractory Prostate Cancer
Intervention:
7 Not yet recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Intervention: Drug: onapristone
8 Unknown  Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Biological: PEP-223/CoVaccine HT
9 Recruiting Prospective Sexual Function Study for BPH Subjects
Condition: Prostatic Hyperplasia
Interventions: Drug: Dutasteride plus tamsulosin;   Drug: Placebo
10 Recruiting Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH
Conditions: Lower Urinary Tract Symptoms;   Benign Prostatic Hyperplasia
Interventions: Procedure: Transurethral resection of the prostate;   Procedure: Holmium Laser Enucleation of the Prostate
11 Not yet recruiting GreenLight XPS Laser System Retrospective Chart Review
Condition: Benign Prostatic Hyperplasia
Intervention: Device: GreenLight XPS Laser System
12 Recruiting C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma
Conditions: Prostate Cancer;   Prostate Adenocarcinoma
Intervention: Drug: C11-Sodium Acetate
13 Recruiting Surgery Combined With Intensity Modulated Radiation Therapy - Image-Guided Radiation Therapy (IMRT-IGRT) in Locally-advanced Prostate Cancers
Conditions: Prostate Cancer;   Prostate Adenocarcinoma
Intervention: Procedure: Surgery combined with IMRT-IGRT
14 Recruiting Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRS
Condition: Prostate Cancer
Intervention:
15 Unknown  Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer
Conditions: Impotence;   Prostatic Neoplasms
Interventions: Drug: Sildenafil therapy plus post-NSRRP HBO2T;   Drug: Sildenafil therapy plus sham post-NSRRP HBO2T
16 Recruiting Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: triptorelin;   Procedure: adjuvant therapy;   Radiation: 3-dimensional conformal radiation therapy
17 Recruiting Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms
Condition: Prostatic Neoplasms
Interventions: Drug: Radium-223 dichloride (Xofigo, BAY88-8223);   Drug: Matching placebo (normal saline);   Drug: Abiraterone;   Drug: Prednisone/Prednisolone
18 Recruiting Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Biological: ipilimumab;   Other: laboratory biomarker analysis
19 Recruiting Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer
Condition: Castrate Resistent Prostate Cancer
Intervention: Biological: BPX-201 vaccine plus AP1903
20 Recruiting A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer
Conditions: Small Cell Prostate Cancer;   Neuroendocrine Prostate Cancer;   Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers
Intervention: Drug: MLN8237

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years